obviously. That’s with all products/drugs. Majority of Drugs on Market is not for everyone. With serious diseases like cancer, it’s a small% success rate. Majority of cancer drugs improves your life in the short term. You can interpret that as ‘not working’ just kicking the can down the road. Patient will die from a disease like cancer.
There is evidence stem cells can prolong a patients life. Yes. A lot of work to be done and yes FDA hasn’t approved it yet, but they are open for discussion. I see this as positive. MSB just needs one approval and you will see pharmaceuticals come to the party.
Bunch of losers?, page-35
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $1.133M | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 151980 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.0¢ | 29989 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |